Ivonescimab shows survival benefit in lung cancer study
Go back to Ivonescimab shows survival benefit in lung cancer study| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 15.11 +0.17 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.94 | 52 Week High | $19.75 | |||
| Open | $14.73 | 52 Week Low | $4.26 | |||
| Day High | $15.35 | P/E | N/A | |||
| Day Low | $14.60 | EPS | $0.00 | |||
| Volume | 2,307,450 | |||||
